Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients.

Authors

Bradley C. Clark, George Washington UniversityFollow
Justin Georgekutty, George Washington University
Charles I Berul, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

9-2015

Journal

Journal of pediatrics

Volume

167

Issue

3

Inclusive Pages

757-761

DOI

10.1016/j.jpeds.2015.06.001

Keywords

Cannabinoids--adverse effects; Designer Drugs--adverse effects; Myocardial Ischemia--chemically induced

APA Citation

Clark, B. C., Georgekutty, J., & Berul, C. I. (2015). Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients. The Journal of Pediatrics. Journal of Pediatrics, 167(3), 757-761. doi: 10.1016/j.jpeds.2015.06.001

Peer Reviewed

1